Fluconazole is a triazole antifungal used for susceptible Candida infections and selected systemic mycoses; it inhibits fungal ergosterol synthesis and has excellent oral bioavailability, but dose and duration vary from a single dose for uncomplicated vaginal candidiasis to prolonged therapy for invasive or central nervous system infection.
Key Insights
- A single 150 mg dose is familiar for uncomplicated vaginal candidiasis, but that regimen should not be generalized to oral, bloodstream or meningeal fungal infections.
- Fluconazole reaches useful concentrations in cerebrospinal fluid and urine, which distinguishes it from several other azole antifungals.
- It inhibits CYP2C9, CYP2C19 and to a lesser degree CYP3A4, creating clinically important interactions with drugs including warfarin and certain anticonvulsants.
- Liver injury and QT prolongation are uncommon but meaningful concerns during higher-dose or prolonged treatment.
- Species-level susceptibility matters because Candida krusei is intrinsically resistant and Candida glabrata often has reduced susceptibility.
Fluconazole: One Tablet Can Be Enough for Some Infections, Not All
Fluconazole is a triazole antifungal, and the familiar 150 mg single tablet has become strongly associated with vaginal yeast infection. That association is accurate for selected uncomplicated cases, but it can create the false impression that every fungal infection is treated with one pill. Oral thrush, esophageal candidiasis, systemic Candida infections and cryptococcal disease use very different doses and treatment lengths.
The drug blocks a fungal enzyme required to make ergosterol, an essential component of the fungal cell membrane. Human cells use different sterols, which gives fluconazole useful selectivity, but the medicine still affects liver enzymes that metabolize many other drugs. Its interaction list is therefore more significant than the simplicity of a single tablet suggests.
When 150 mg Is Commonly Used
For uncomplicated vulvovaginal candidiasis in many nonpregnant adults, a single 150 mg oral dose is a standard regimen. Recurrent or severe disease may require repeat doses or longer suppressive plans under medical supervision. Persistent symptoms should not automatically trigger repeated self-dosing because bacterial vaginosis, sexually transmitted infections, dermatitis and resistant Candida species can mimic or complicate yeast symptoms.
Other fungal infections often use daily dosing for days, weeks or months. The prescription indication is therefore essential. A product strength tells you what is in the tablet, not how many tablets make an appropriate course.
Liver, Heart Rhythm and the Interaction List
Fluconazole can elevate liver enzymes and, rarely, cause serious hepatic injury. Patients with existing liver disease or prolonged high-dose treatment may need laboratory monitoring. Yellowing of the skin or eyes, dark urine and marked fatigue should prompt evaluation.
The drug can also prolong the QT interval, particularly in susceptible patients or when combined with other QT-prolonging medicines. Electrolyte problems such as low potassium can increase this risk.
- List warfarin, seizure medicines, diabetes tablets, statins and heart-rhythm drugs before treatment.
- Do not assume recurring vaginal symptoms are always Candida.
- Pregnancy changes the risk discussion; oral fluconazole is not the routine first choice for uncomplicated yeast infection in pregnancy.
- Seek advice for jaundice, fainting, severe rash or persistent symptoms after treatment.
Why Warfarin and Sulfonylureas Come Up So Often
Fluconazole inhibits several CYP enzymes. It can raise warfarin effect and increase bleeding risk. It may increase concentrations of some sulfonylurea diabetes drugs, raising hypoglycemia risk. Phenytoin levels can rise, and some statins become more likely to cause muscle toxicity. The exact interaction depends on dose and duration, but a one-tablet treatment still deserves a medication review in patients taking drugs with narrow safety margins.
Rifampin can lower fluconazole exposure, while other drugs can amplify its QT effect. The safest approach is not to memorize every pair but to treat fluconazole as a systemic medication, not as the oral equivalent of an over-the-counter skin cream.
Pregnancy and Recurrent Yeast Infection
High-dose, prolonged fluconazole exposure in pregnancy has been associated with fetal harm, and clinical guidance generally favors topical azole therapy for uncomplicated vulvovaginal candidiasis during pregnancy. A patient who could be pregnant should discuss the preferred treatment rather than automatically taking an oral tablet because it is convenient.
Recurrent candidiasis can also point to diabetes, antibiotic exposure, immune problems or a Candida species less susceptible to fluconazole. Culture or specialist assessment becomes more useful when symptoms keep returning or do not respond to appropriate treatment.
| Situation | Typical approach |
|---|---|
| Uncomplicated vaginal Candida | Often a single 150 mg dose in appropriate nonpregnant adults |
| Recurrent disease | May use induction plus longer suppressive therapy |
| Oral/esophageal Candida | Usually repeated daily dosing, not one tablet |
| Systemic fungal infection | Specialist dosing and monitoring |
Generic Fluconazole and Mexican Supply
Diflucan is the classic originator brand associated with Pfizer, while generic fluconazole is manufactured widely. Mexican pharmacies may stock several generic presentations, and the same 150 mg active ingredient can arrive in different carton designs.
The product listing here currently shows generic / varies by current supply source as the supply/manufacturer field and $43.99 as the price. That figure applies to this catalog listing. The actual package should confirm fluconazole, strength, manufacturer, lot and expiry before use.
When an Antifungal Should Not Be Repeated Blindly
Itching and discharge are symptoms, not microbiology. A patient who repeatedly buys fluconazole without confirming the diagnosis can temporarily suppress symptoms while missing a different condition. The same is true of oral thrush that returns after every course; a cause such as inhaled corticosteroid residue, dentures, diabetes or immune suppression may be sustaining the problem.
Fluconazole is effective because it targets susceptible fungi systemically. Its convenience is real, but convenience should not erase the distinction between one uncomplicated yeast infection and a recurring pattern that deserves investigation.
Resistance Is Becoming More Important
Not every Candida species responds equally to fluconazole. Candida glabrata may have reduced susceptibility, while Candida krusei is intrinsically resistant. Repeated exposure to azoles can also select for less susceptible organisms. That is one reason recurrent or refractory infection deserves culture rather than endless single-dose treatment.
This distinction is especially important in immunocompromised patients or people with invasive infection, where choosing an active antifungal can be life-saving. The one-tablet reputation of fluconazole belongs to a narrow everyday use; serious fungal disease is a different clinical world.
